Nelarabine 70121-1743
Product NDC
70121-1743- Manufacturer
- Amneal Pharmaceuticals Llc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 10, 2023
- Listing Expires
- December 31, 2027
- Application
- ANDA216346
Need to source Nelarabine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Nelarabine | 5 mg/mL |
Drug Class
Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]
Packaging Options(2)
1 VIAL, SINGLE-DOSE in 1 CARTON (70121-1743-1) / 50 mL in 1 VIAL, SINGLE-DOSE
6 VIAL, SINGLE-DOSE in 1 CARTON (70121-1743-4) / 50 mL in 1 VIAL, SINGLE-DOSE